. COSY spectrum (500 MHz, CDCl 3 ) for gracilin G (1) p3 Figure S4 . HSQC spectrum (500 MHz, CDCl 3 ) for gracilin G (1) p4 Figure S5 . HMBC spectrum (500 MHz, CDCl 3 ) for gracilin G (1) p5 Figure S6 . 1 H NMR spectrum (500 MHz, CDCl 3 ) for gracilin M (2) p6 Figure S7 . COSY spectrum (500 MHz, CDCl 3 ) for gracilin M (2) p7 Figure S8 . HSQC spectrum (500 MHz, CDCl 3 ) for gracilin M (2) p8 Figure S9 . HMBC spectrum (500 MHz, CDCl 3 ) for gracilin M (2) p9 Figure S10 . NOESY spectrum (500 MHz, CDCl 3 ) for gracilin M (2) p10 Figure S11 . EXSIDE spectrum (750 MHz, CDCl 3 ) for gracilin M (2); (A) signal for H-7 with 3 J interaction to C-1 and to C-5; (B) expansion showing 3 J interaction to C-1 p11 Figure S12 .
1 H NMR spectrum (500 MHz, CDCl 3 ) for gracilin N (3) p12 Figure S13 . COSY spectrum (500 MHz, CDCl 3 ) for gracilin N (3) p13 Figure S14 . HSQC spectrum (500 MHz, CDCl 3 ) for gracilin N (3) p14 Figure S15 . HMBC spectrum (500 MHz, CDCl 3 ) for gracilin N (3) p15 Figure S16 .
1 H NMR spectrum (500 MHz, CDCl 3 ) for gracilin O (4) p16 Figure S17 . 1 H NMR spectrum (500 MHz, CDCl 3 ) for gracilin P (5) p17 Figure S18 .
1 H NMR spectrum (500 MHz, CDCl 3 ) for gracilin Q (6) p18 Figure S19 .
1 H NMR spectrum (500 MHz, CDCl 3 ) for aplytandiene-3 (7) p19 Figure S20 . COSY spectrum (500 MHz, CDCl 3 ) for aplytandiene-3 (7) p20
ii Figure S21 . HSQC spectrum (500 MHz, CDCl 3 ) for aplytandiene-3 (7) p21 Figure S22 . HMBC spectrum (500 MHz, CDCl 3 ) for aplytandiene-3 (7) p22 Figure S23 . 1 H NMR spectrum (500 MHz) for daphnelactone (16) p23 Figure S24 . 1 H NMR spectrum (900 MHz, CDCl 3 ) for fraction containing daphnelactone (16) p24 Figure S25 .
13 C NMR spectrum (900 MHz, CDCl 3 ) for fraction containing daphnelactone (16) p25 Figure S26 . COSY spectrum (900 MHz, CDCl 3 ) for fraction containing daphnelactone (16) p26 Figure S27 . HSQC spectrum (900 MHz, CDCl 3 ) for fraction containing daphnelactone (16) p27 Figure S28 . HMBC spectrum (900 MHz, CDCl 3 ) for fraction containing daphnelactone (16) p28 Figure S29 . NOESY spectrum (900 MHz, CDCl 3 ) for fraction containing daphnelactone (16) 1 H NMR spectrum (500 MHz, CDCl 3 ) for aplytandiene-3 (7) Figure S20 . COSY spectrum (500 MHz, CDCl 3 ) for aplytandiene-3 (7) Figure S21 . HSQC spectrum (500 MHz, CDCl 3 ) for aplytandiene-3 (7) Figure S22 . HMBC spectrum (500 MHz, CDCl 3 ) for aplytandiene-3 (7) Figure S23 . 
Molecular Modeling and DFT calculations.
Monte Carlo Conformational searching was performed using Macromodel v10.0(Schrodinger) a for diastereomers 1-6R and 1-6S. Torsional sampling (MCMM) was performed with 1000 steps per rotatable bond. Each step was minimised with the OPLS-2005 force field using TNCG method with maximum iterations of 50,000 and energy convergence threshold of 0.02. All other parameters were left as the default values. The lowest energy conformations (< 3 kcal/mol from global minimum, 10 and 8 conformers for 1-6R and 1-6S respectively) were further optimised using DFT calculations in Jaguar b .
All conformers were optimised using B3LYP/6311+G(d,p) in vacuum using the Jaguar v8.0 (Schrodinger) b . All conformations were compared and any identical conformers removed. This resulted in 10 and 7 unique conformers for 1-6R and 1-6S respectively. The energies for each diastereomers were used to obtain a Boltzmann averaged torsion angle and this was used to calculate the coupling constant using equation 1 (Aydin c ) and are details are shown in Tables S1  and S2 . (1) where ɸ is the torsion angle in radians 
